Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.

Citation

• de Souza, P. L., Capp, A. L., Chikhladze, N., Mezvrishvili, Z., Messina, M., & Mautner, G. (2020). Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology, 38(15_suppl), 5533. doi:10.1200/jco.2020.38.15_suppl.5533

Digital Object Identifier (doi)

• 10.1200/jco.2020.38.15_suppl.5533

Web Of Science Accession Number

Start Page

• 5533

End Page

• 5533

Volume

• 38

Issue

• 15_suppl

Place Of Publication

Abstract

UOW Authors

•   De Souza, Paul (external author)

Publication Date

• 2020

Publisher

• American Society of Clinical Oncology (ASCO) 

Published In

• Journal of Clinical Oncology  Journal

Citation

• de Souza, P. L., Capp, A. L., Chikhladze, N., Mezvrishvili, Z., Messina, M., & Mautner, G. (2020). Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology, 38(15_suppl), 5533. doi:10.1200/jco.2020.38.15_suppl.5533

Digital Object Identifier (doi)

• 10.1200/jco.2020.38.15_suppl.5533

Web Of Science Accession Number

Start Page

• 5533

End Page

• 5533

Volume

• 38

Issue

• 15_suppl

Place Of Publication